SUMMARY Serum from 23 of 26 patients with fulminant hepatic failure and grade IV encephalopathy had defective opsonisation of E. coli and yeast (S. cerevisiae) 
Bacterial infection is a common complication of fulminant hepatic failure' and has been implicated as the main cause of death in 11% of fatal cases.2 Normally the removal of bacteria from the blood requires serum factors, immunoglobulin, and complement, which coat (opsonise) the bacteria before they are ingested and killed by the polymorphonuclear leucocytes. Congenital deficiency of individual complement factors or immunoglobulin markedly increases susceptibility to infection. [3] [4] [5] In this paper we describe investigations into opsonisation by serum from patients with fulminant hepatic failure. Two organisms, Escherichia coli and yeast (Saccharomyces cerevisiae), which have different opsonisation requirements were used. We also investigated the relationship between the opsonisation defect measured in vitro and the deficiency in complement factors in the same patients.
Methods

PATIENTS
Serum samples were obtained serially from 26 patients with fulminant hepatic failure after they had developed grade IV encephalopathy. The cause of their liver damage was paracetamol self-poisoning in 14, viral hepatitis in nine (two HBsAg-positive), Received for publication 19 February 1980 and multiple exposure to halothane in three. Seven patients (two hepatitis, five paracetamol selfpoisoning) recovered completely. Full supportive therapy was given including intravenous dextrose, cimetidine, dexamethasone (for cerebral oedema), vitamin supplements, lactulose orally, and magnesium sulphate enemas. Liver support by means of daily periods of four to six hours' haemodialysis with a polyacrylonitrile membrane was needed in all patients, expecially in 11 who developed renal failure (creatinine >200 ,mol/l). Three patients developed bacterial septicaemia after admission and a fourth had E. coli septicaemia on admission. Three of the four patients with infection survived and in the other the immediate cause of death was cerebral oedema rather than the infection. Antibiotics were given to three patients with proven infection and to nine with suspected bacterial infection.
Venous blood samples were taken daily before haemodialysis, from the time of the first signs of grade IV encephalopathy until death or recovery. Blood was allowed to clot for two hours at room temperature before separation of serum, which was either used immediately or stored in aliquots at -196°C until the time of assay. 
Figures in parentheses show number of patients studied.
organism and the aetiology or clinical outcome of the hepatic necrosis. The results of the serial measurements in 10 of the fatal cases showed a progressive reduction in opsonisation indices in eight while, in seven of the patients who recovered, serial studies were available during the period of improvement in five. In all cases serum opsonisation indices for both E. coli and yeasts returned to normal, in three patients between one and nine days after all signs of encephalopathy had disappeared (between two and 10 days after admission). There was, however, no correlation with the level of consciousness, some minor signs of encephalopathy still being present in two other patients when opsonisation indices had returned to normal.
Experiments with polymorphonuclear leucocytes from four patients, in the presence of autologous serum, showed the E. coli opsonisation index to be reduced, with a mean value of 31-5. In the presence of control serum pool the cells functioned normally, with a mean opsonisation index of 98-75.
CHARACTERISATION OF SERUM ABNORMALITY
Dialysis in vitro against Hank's balanced salt solution for 12 hours at 4°C had no effect; mean yeast opsonisation index in the five patients studied was 60.5 before and 53 after dialysis (P>0.5, paired t-test). Similarly, serum obtained immediately before and after treatment by polyacrylonitrile membrane dialysis in five patients gave mean opsonisation values for yeast of 56.3 and 39 respectively and for E. coli 88-3 and 76-3 respectively (Table 2 ). These findings indicate that the serum defect was not caused by a toxic substance of low molecular weight.
To examine for the action of a non-dialysable toxic serum factor, normal polymorphonuclear leucocytes were incubated for one hour at 37°C in a 10% dilution of serum from nine patients known to have defective opsonisation. When normal polymorphonuclear leucocytes treated in this way were incubated with E. coli or yeast cells already opsonised Control serum diluted with buffer 0 14-3 53 100
Numbers do not denote the same patients as in Table 2 by preincubation in control serum pool, a mean of 99.3% E. coli and 100% yeast cells were phagocytosed, indicating no impairment of leucocyte function.
To determine whether the defect was due to a deficiency of normal opsonisation factors, serum from patients and from control serum pool were mixed together in different porportions. Severe defects of E. coli opsonisation by serum from three cases were totally corrected by the addition of control serum pool at concentrations of 0.25, 0-33, and 2%. As control serum pool in a concentration of 1 % in the absence of patients' serum was only able to opsonise 35% of E. coli, the contribution by patients' serum in these experiments is greater than immediately apparent. Similar studies of yeast opsonisation by serum from three other patients showed that the defect could be totally corrected by addition of 0.5 and 1% control serum pool (Table 3) , while control serum pool at a concentration of 0.5 and 1% in the absence of patients' serum opsonised only 14 and 53% of yeasts respectively ( In six of the seven patients (two hepatitis, five paracetamol self-poisoning) who regained consciousness, complement factor activity returned to normal in four cases between three and nine days and in two cases between time of discharge (two and nine days respectively after all signs of encephalopathy had disappeared) and follow-up at one and 29.7+17-6 39-2±23.8 25.6+17.5 9-3±13.7 23+7.4
16-2±14-8 9-6±10
(7) (6) (7) (7) (7) (6) 
Viral hepatitis 32-1±31-7 37±37.7
26.8±20-1 26-4±18.6 32.3+±14 23.9±12-1w 33.8±18-9 (8)
(8)
Figures in parentheses represent number of patients studied. *0.05 >p>>002 (Wilcoxon's rank sum test). six months respectively. The activity of the alternative pathway tended to recover earlier and more rapidly than that of the classical pathway and was paralleled by a return to normal of opsonisation ( Figure) . of normal serum needed to correct the opsonisation defect is consistent with complement deficiency rather than immunoglobulin as the cause of the defective opsonisation. Additional evidence is the reduction of complement factors in the sera of patients at a time when opsonisation defects were most markedly affected and the good correlations between improvement in serum opsonisation and complement activity during the acute stages of recovery. The correlation between the recovery of the alternative pathway activity and E. coli opsonisation should be interpreted with caution, in view of the correction achieved by the addition of normal serum depleted of factor B (RB), which suggests a defect in the classical pathway. The liver is the major site of synthesis of complement factors and the fact that serum complement and opsonisation returned to normal during recovery is evidence that these defects are not congenital but secondary to the hepatic necrosis. Markedly lowered complement levels have been reported in patients with acute hepatic necrosis16 and less severe defects in viral hepatitis due either to reduced synthesis or increased catabolism.'719 In our patients consumption of complement may have been increased especially in cases with acute viral hepatitis in whom circulating immune complexes are raised. Similar defects in complement and opsonisation, however, were present in hepatic necrosis caused by paracetamol self-poisoning (D Vergani, personal communication) in which immune complexes are almost always absent. The complement deficiences in our patients are severe and affect several factors to a degree associated with impaired host defence against infection in other congenital and acquired complement deficiency states.3520
GRADE OF ENCEPHALOPATHY
The importance of these findings is shown by the occurrence of bacterial infection in four (15%) of the cases at a time when serum opsonisation and complement factors were severely reduced. Reports of congenital deficiency of serum opsonisation21 suggest that transfusions of fresh blood or freshly prepared plasma provide the most effective replacement therapy. While opsonisation returned to normal in one patient, the failure of small transfusions of fresh frozen plasma in other cases may have been due to the insufficient volume of the transfusion or to the fact that the plasma had been stored and was not freshly separated. As in other diseases, infection can be overwhelming in the presence of such defects of host defence and attempts to correct these in fulminant hepatic failure should prove worthwhile. 
